These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35253348)

  • 1. Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia.
    Groot Jebbink E; van Wijck I; Holewijn S; Iida O; Spinelli D; Saxon RR; Zeller T; Okhi T; Bosiers M; Reijnen MMPJ
    Catheter Cardiovasc Interv; 2022 Apr; 99(5):1714-1722. PubMed ID: 35253348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post hoc analysis of the SuperB and Zilverpass trials for treatment of long and complex superficial femoral artery lesions.
    van Walraven LA; Kalil VM; van der Veen D; Bosiers MJ; Deloose K; Holewijn S; Zeebregts CJ; Reijnen MMPJ
    J Vasc Surg; 2024 Aug; 80(2):505-514.e2. PubMed ID: 38604319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
    Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
    J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
    Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
    J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
    Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
    AbuRahma AF; Beasley M; AbuRahma ZT; Davis M; Adams E; Dean LS; Shapiro J; Scott G; Davis E
    J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
    Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
    J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
    Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
    Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Long-Term Outcomes of Femoropopliteal Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia in an Endovascular Era.
    Betz T; Ingolf T; Markus S; Florian Z; Christian U
    Ann Vasc Surg; 2022 Feb; 79():191-200. PubMed ID: 34644653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial.
    Böhme T; Noory E; Brechtel K; Scheinert D; Bosiers M; Beschorner U; Zeller T
    J Endovasc Ther; 2021 Apr; 28(2):222-228. PubMed ID: 33044119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
    Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
    J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year outcomes of the GORE VIABAHN Endoprosthesis for the treatment of complex femoropopliteal lesions from a Japanese postmarket surveillance study.
    Iida O; Ohki T; Soga Y; Suematsu N; Nakama T; Yamaoka T; Tobita K; Ichihashi S
    Vasc Med; 2024 Aug; 29(4):416-423. PubMed ID: 38544413
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
    Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
    J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter
    Iida O; Takahara M; Soga Y; Yamaoka T; Nanto S; Kuratani T; Sakata Y; Mano T
    J Endovasc Ther; 2021 Feb; 28(1):123-131. PubMed ID: 32959718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia.
    Kum S; Ipema J; Huizing E; Tan YK; Lim D; Lok IY; Hazenberg CE; Ünlü Ç
    Vasc Med; 2021 Jun; 26(3):267-272. PubMed ID: 33733963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.